565 related articles for article (PubMed ID: 17214854)
1. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma.
Ko CJ; Iftner T; Barr RJ; Binder SW
J Cutan Pathol; 2007 Jan; 34(1):44-8. PubMed ID: 17214854
[TBL] [Abstract][Full Text] [Related]
2. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis.
Li YH; Chen G; Dong XP; Chen HD
Br J Dermatol; 2004 Nov; 151(5):1060-5. PubMed ID: 15541085
[TBL] [Abstract][Full Text] [Related]
3. Incidental epidermodysplasia verruciformis human papillomavirus infection (EV acanthoma): evidence for 'field cancerization' and a putative cofactor in seborrheic keratosis.
Rohwedder A; Foong H; Tyring SK; Rady P; Carlson JA
J Cutan Pathol; 2008 Dec; 35(12):1151-5. PubMed ID: 18494819
[No Abstract] [Full Text] [Related]
4. Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis.
Roncalli de Oliveira W; Neto CF; Rady PL; Tyring SK
J Dermatol; 2003 Jan; 30(1):48-53. PubMed ID: 12598709
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
6. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
7. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
Carlson JA; Cribier B; Nuovo G; Rohwedder A
J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
9. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer.
de Jong-Tieben LM; Berkhout RJ; ter Schegget J; Vermeer BJ; de Fijter JW; Bruijn JA; Westendorp RG; Bouwes Bavinck JN
Transplantation; 2000 Jan; 69(1):44-9. PubMed ID: 10653378
[TBL] [Abstract][Full Text] [Related]
11. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
Majewski S; Jablonska S
Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
[TBL] [Abstract][Full Text] [Related]
12. [HPV-20-induced epidermodysplasia verruciformis].
Wätzig V; Jablonská S
Hautarzt; 1987 Sep; 38(9):521-4. PubMed ID: 2826363
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the expression of cytokeratins (1, 10, 14, 16, 4), involucrin, filaggrin and e-cadherin in plane warts and epidermodysplasia verruciformis plane wart-type lesions.
Barcelos AC; Sotto MN
J Cutan Pathol; 2009 Jun; 36(6):647-54. PubMed ID: 19515043
[TBL] [Abstract][Full Text] [Related]
14. Seborrheic keratosis-like lesions in epidermodysplasia verruciformis.
Tomasini C; Aloi F; Pippione M
J Cutan Pathol; 1993 Jun; 20(3):237-41. PubMed ID: 8396161
[TBL] [Abstract][Full Text] [Related]
15. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
16. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome.
Kreuter A; Hochdorfer B; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U;
Arch Dermatol; 2008 Mar; 144(3):366-72. PubMed ID: 18347293
[TBL] [Abstract][Full Text] [Related]
17. Lesions With an Epidermal Hyperplastic Pattern: Morphologic Clues in the Differential Diagnosis.
Fernandez-Flores A
Am J Dermatopathol; 2016 Jan; 38(1):1-16; quiz 17-9. PubMed ID: 26730692
[TBL] [Abstract][Full Text] [Related]
18. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
19. HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV 25.
de Oliveira WR; He Q; Rady PL; Hughes TK; Neto CF; Rivitti EA; Tyring SK
J Cutan Med Surg; 2004; 8(2):110-5. PubMed ID: 15129315
[TBL] [Abstract][Full Text] [Related]
20. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach.
Surentheran T; Harwood CA; Spink PJ; Sinclair AL; Leigh IM; Proby CM; McGregor JM; Breuer J
J Clin Pathol; 1998 Aug; 51(8):606-10. PubMed ID: 9828820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
